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Objective: To examine the role of thrombolysis alone, or in conjunction with surgery and angioplasty, in the treatment of 
thromboembolic disorders. 
Design: A retrospective r view of 70 patients, who received thrombolysis on 73 occasions between 1990 and 1993. 
Patients and methods: Four groups were defined: (1) thrombolysis alone (40%); (2) thrombolysis followed by angioplasty 
(23%); (3) thrombolysis followed by surgery (13%) and (4) thrombolysis after failed angioplasty (24%). 
Results: Twenty-eight patients (40%) received thrombolysis alone of which 13 were successful. In 25 cases (36%) 
thrombolysis was initially successful in that it permitted further angioplasty or surgical reconstruction. This adjunctive 
treatment was successful in 16 cases. Overall, when used as a first-line treatment, hrombolysis was successful in 72% of 
cases. Success in this context includes those in which a further procedure was possible after thrombolysis. These groups 
included 20 occluded grafts in which thrombolysis played an important part in unblocking 13 (65%) of them. In a separate 
group of 17 patients (24%) thrombolysis was given after failed angioplasty and was successful on 15 (88%) occasions. Local 
complications occurred in 17 patients. There were three deaths. There were no intra-cerebral haemorrhages. 
Conclusions: Thrombolysis alone can be used successfully. There is a large group in which thrombolysis can help to 
increase the success rate of interventional radiology. 
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Introduction 
Increasingly, the relative merits of surger~ angioplasty 
and thrombolysis in the management of thromboem- 
bolic disorders are being discussed. ~ The development 
of the Fogarty catheter in 19632 increased the success 
rate of surgical embolectomy. This was the accepted 
firstqine treatment of most embolic occlusions. 3 How- 
ever, the place of surgical and non-surgical techniques 
in the management of embolic and thrombotic dis- 
orders, is far from clear. 4
Even though streptokinase was discovered in 
1933, 5 it was not until 1962 that Cotton et al. 6 described 
its intra-arterial use in the treatment of thrombosed 
popliteal aneurysms. The last five years has seen an 
increase in the use of both streptokinase and rTPA in 
the treatment of thromboembolic disease. 7 
In this stud~ we review our four-year experience 
of thrombolytic therapy. The two main objectives 
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were: (1) to define the pattern of thrombolytic usage 
and (2) to establish whether thrombolysis alone is a 
successful treatment of thromboembolic disorders. 
Patients and Methodology 
The case notes of 70 patients receiving thrombolysis 
between 1990 and 1993 were reviewed retrospectively. 
Three of these had two separate pisodes or limbs 
requiring thrombolysis. There were, therefore, 73 
occasions on which thrombolysis was given. 
Exclusion from thrombolysis 
The following situations were considered absolute 
contraindications for thrombolysis: (a) immediate 
limb threatening ischaemia, amenable to surgery; (b) 
gastrointestinal bleeding within the previous 3 weeks; 
(c) a cerebrovascular event within 2 months; (d) 
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known bleeding diatheses; (e) recent major trauma or 
cardiopulmonary resuscitation (CPR). While it is 
difficult to define 'recent' in the above context, most 
people would not give thrombolysis within 2 weeks of 
CPR, major trauma or major surgery. Some would 
wait as long as 6 weeks. The relative contraindications 
were: (a) peptic ulceration; (b) renal or hepatic 
failure. 
Technique 
All patients were consented before the procedure, 
which was performed in the supine position. An 
angiographic catheter was introduced, preferably 
from the contralateral groin, using the Seldinger 
technique. The sidewinder or multisidehole catheter 
was then positioned just proximal or just within the 
occlusion. Streptokinase was infused at a standard 
rate of 5000 units per hour. This was then increased in 
some subjects, to a tnaximum of 20 000 units per hour 
in one patient, rTPA was infused at a rate of 0.5 mg per 
hour in 10 ml of normal saline. 
After initiating thrombolysis, the patients were 
closely monitored, either on the intensive care unit or 
specialist vascular ward, in most cases the latter. 
Cardiovascular status and the status of the extremity 
by listening for Doppler signals were assessed 
hourly. 
A check angiogram was performed at 4 h and 
thereafter at times determined by the findings, usually 
4-hourly. Thrombolysis was continued until successful 
or a further procedure was deemed necessary (i.e. 
angioplasty or surgery). Thrombolysis was stopped if: 
(a) no lysis occurred after 4 h; (b) there was failure to 
progress at any of the subsequent checks; (c) complica- 
tions intervened or the leg deteriorated. 
Results 
18 cases before commencing thrombolysis. Fifty-five 
(79%) patients were present or ex-smokers. Fourteen 
(20%) had diabetes mellitus and a further 20 (29%) had 
hypertension. The thrombolytic agent used was strep- 
tokinase on 40 occasions (55%) and rTPA on 33 (45%). 
The average infusion time was 24 hours (range 1-66 
hours). 
Thrombolysis had to be stopped in three (4%) of 
the 70 patients. One patient pulled out the angiogram 
catheter, one fell sustaining a forehead haematoma 
and one had haemoptysis. Therefore, the results of 70 
episodes of thrombolysis are presented. 
The use of thrombolysis could be divided into 
four separate groups: (1) thrombolysis alone; (2) 
thrombolysis followed by angioplasty; (3) thrombol- 
ysis followed by surgery; (4) angioplasty followed by 
thrombolysis. We define success as functional imb 
salvage at 30 days in each particular group. The results 
are illustrated in Fig. 1. 
Twenty-eight patients (40%) had thrombolysis 
alone; of these only two had symptoms of intermittent 
claudication. Twenty-six had symptoms of rest pain, 
the duration of symptoms ranging from sudden onset 
to 6 months. Overall, 13 patients had improved 
symptoms and hence definitive treatment from throm- 
bolysis alone, with no adjunctive procedure. Three 
patients in this group had embolic episodes. Two of 
these were angiographically proven. The third patient 
had had a myocardial infarction 2 weeks previously 
and was in atrial fibrillation. 
In 25 (36%) thrombolysis was successful but an 
underlying lesion required a further procedure. In 16 
cases, an underlying stenosis amenable to angioplasty 
could be identified. Angioplasty failed in two cases. 
There was poor run-off in a further two patients: these 
were considered failures. These four failures pro- 
ceeded to successful surgical reconstruction. 
In nine cases, thrombolysis mproved the run-off 
sufficiently to allow reconstructive surgery. This was 
unsuccessful in three cases, of which one had a 
diagnosis of embolus. 
Fifty patients (71%) were male and 20 (29%) were 
female. The mean age was 67 years (range 39-85 
years). The mean duration of symptoms was 8 days (1 
hour to 3 months). Fifty-seven cases (78%) had critical 
ischaemia on presentation and 16 (22%) had inter- 
mittent claudication. Of the 57 patients, the aetiology 
was an embolus in five, thrombosis of a routine vessel 
in 36 and a graft occlusion in 16. Critical ischaemia in 
this context was defined as rest pain with neurological 
symptoms. Some had additional tissue loss. It was 
estimated that there was irreversible limb ischaemia in 
Total Number 
70 
T Alone T Angioplasty T Surgery Angioplasty T 
28 16 9 17 
Success Fail Success Fail Success Fail Success Fail 
13 15 12 4 6 3 15 , 2 
Fig. 1. The overall results of thrombolysis (T = thrombolysis) 
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Table 1. Complications from intraarterial thrombolysis 
Type Number 
Local 
Minor (no transfusion) 11 
Major (transfusion) 6 
General 
Deaths 3 
Haematemesis (no transfusion) 1 
Thrombolysis was used to improve run-off or 
clear new thrombus after 17 angioplasties. This was 
successful in 15 cases. In one of these cases, angio- 
plasty was preceded by a suction thrombectomy. A 
diagnosis of embolus was proven angiographically in 
this case. In two cases, thrombolysis failed after 
angioplasty. One of these patients improved radio- 
graphically but acquired a surgical thrombectomy. The 
second patient suffered an arterial dissection and 
required reconstructive surgery. 
Twenty patients (29%) had grafts. There were 
equal numbers of vein and synthetic grafts (Fig. 2). 
Thrombolysis helped unblock 13 (65%) grafts success- 
fully. In seven (54%) of these cases, thrombolysis alone 
was used. Five (38%) had successful redo recon- 
structive surgery following thrombolysis. One had a 
successful angioplasty. Four cases (20%) had unsuc- 
cessful treatment with thrombolysis alone; all required 
amputations. In two patients, angioplasty failed after 
partially successful thrombolysis. These both 
proceeded to successful surgery. In one further 
patient, a surgical thrombectomy failed following 
thrombolysis. 
There were 17 local and four general complica- 
tions. These are listed in Table 1. 
In considering the three deaths, one case had a 
retroperitoneal bleed from the puncture site. One 
patient suffered a haemoptysis; this may have been 
secondary to a concurrent pneumonia. The third 
patient died as a result of a recent myocardial 
infarction. It should be noted that only one of these 
deaths was directly attributable to the thrombolysis. 
There were no intracerebral haemorrhages. 
Discussion 
The management of acute peripheral ischaemia is a 
difficult problem. 8 Much has been written on the 
successful use of intra-arterial thrombolysis. Despite 
this, few units have reviewed and defined their precise 
use of thrombolysis. 
In cases where thrombolysis was used as a first- 
line treatment (53 cases), our overall success rate was 
72% (38 cases). This includes 25 cases in which 
thrombolysis succeeded in that it permitted a further 
procedure such as angioplasty or reconstructive sur- 
gery. These further procedures were successful on 18 
occasions. Thrombolysis alone was successful in 13 
(25%) cases. These figures compare well with pooled 
data as quoted by Graor and Olin. 9 He quotes uccess 
rates of 67% for streptokinase and 90% for rTPA. He, 
however, does not define what is meant by "successful 
thrombolysis'. Our figures also compare well with 
prospective data, where the limb salvage rate is 
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Fig. 2. The results of thrombolysis n occluded grafts (T = thrombolysis) 
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It should be noted that many of the patients in our 
study had irreversible ischaemia. The majority of 
these made up the group of patients in whom 
thrombolysis alone failed. Thrombolysis in these 
patients was used in an attempt to avoid almost 
inevitable amputation. 
In 24% of cases, thrombolysis was used to treat 
arterial occlusion after angioplasty. This was usually 
due to thrombosis at the angioplasty site or distal 
emboli. This figure is greater than the 12% quoted in 
the literatureJ 1 This group is becoming increasingly 
important, as our success rate of 88% implies. There is 
little doubt hat thrombolysis will be used increasingly 
in this role, as interventional radiology becomes more 
aggressive. 
ControversY12still exists over the management of
occluded grafts. This study found that thrombolysis 
alone or in conjunction with surgery or angioplasty 
contributed to the successful management of 65% of 
the graft occlusions offered thrombolytic therapy. It 
should be noted that 35% of the total involved 
thrombolysis alone. Many feel that the best use of 
thrombolysis n graft occlusion is in conjunction with 
subsequent reconstructive surgery. 13' is Initial success 
with thrombolysis alone is often complicated by 
subsequent re-occlusion. This is because the cause for 
the occlusion has not been removed. 
Our local complication rate compared well with 
average figures. It was notable, however, that there 
were no intracranial bleeds. This is in contrast to other 
figures, in which intracerebral bleeding occurs in 
between 2% and 6% of cases. 9
In conclusion, thrombolysis has an important role 
to play in the treatment of peripheral ischaemia. This 
may be alone, or in conjunction with surgery and 
angioplasty. An increasingly relevant use is demon- 
strated in helping to improve the success rate of 
invasive radiological intervention. 
It is appreciated that this is a retrospective study 
of limited numbers. There is a great need for new, 
multicentre, prospective trials. This need is becoming 
greater as new techniques such as pulsed-spra~ 
thrombolysis 16'17 and new thrombolytic agents 
become available. 
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